Novo Nordisk said on Wednesday it would begin selling ... pharmacies had until the court makes its decision in the earlier case to stop selling compounded tirzepatide, but has not said whether ...
In making his ruling, Pittman wrote that "good cause exists for Novo Nordisk's intervention in this case under Federal Rule of Civil Procedure 24." The rule allows for intervention of a third ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback